Biohaven Ltd.
Biohaven Ltd. (BHVN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BHVN · as of Sep 30, 2025
Ownership Breakdown
300
Institutional Holders
▲ 29 vs Q2
$1.27B
Total Inst. Value
▲ $39.04M vs Q2
105.87M
Shares Outstanding
freeFloat 80.00%
84.49M
13F Shares Held
▼ 2.50M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BHVN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 7.87M | 7.69% | 7.69% | $118.20B | Nov 12, 2025 | ▲ 339.6K |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 6.77M | 6.62% | 6.62% | $101.68B | Nov 14, 2025 | ▲ 1.72M |
STIFEL FINANCIAL CORP pharmaceutical preparations | 6.61M | 6.46% | 6.46% | $99.24B | Nov 12, 2025 | ▲ 3.8K |
SUVRETTA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 5.62M | 5.49% | 5.49% | $84.36B | Nov 14, 2025 | — held |
STATE STREET CORP pharmaceutical preparations | 4.26M | 4.16% | 4.16% | $63.92B | Nov 14, 2025 | ▲ 720.1K |
VANGUARD GROUP INC pharmaceutical preparations | 2.88M | 2.81% | 2.81% | $43.16B | Nov 7, 2025 | ▼ 6.37M |
BELLEVUE GROUP AG pharmaceutical preparations | 2.80M | 2.74% | 2.74% | $42.07B | Nov 14, 2025 | — held |
FMR LLC pharmaceutical preparations | 2.43M | 2.37% | 2.37% | $36.43B | Nov 13, 2025 | ▲ 762.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 2.06M | 2.01% | 2.01% | $30.93B | Nov 12, 2025 | ▲ 29.3K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 2.01M | 1.96% | 1.96% | $30.16B | Nov 14, 2025 | ▼ 1.16M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
31
Increased
+15.46M shares2
New Positions
first time holders13
Decreased
−11.28M shares0
Sold Out
fully exitedNet shares change (top 50)
+4.18M
+15.46M / −11.28M
Net new holders
+20
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BHVN insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
7
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Mehta Kishan director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
Bailey Gregory director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
Heffernan Michael Thomas director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
Antonijevic Irina director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
CHILDS JOHN W director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
HUGIN ROBERT J director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
GREGORY JULIA P director | Apr 28, 2026 | Award | 68,693 | $9.61 | $660.1K | 68.7K | Form 4 ↗ |
Mehta Kishan director | Mar 17, 2026 | Gift | 17,342 | — | — | 17.3K | Form 4 ↗ |
Mehta Kishan director | Mar 17, 2026 | Gift | 17,342 | — | — | 5.3K | Form 4 ↗ |
CHILDS JOHN W director | Mar 4, 2025 | Purchase | 28,400 | $30.43 | $864.1K | 2.32M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Biohaven Ltd. (BHVN) is primarily owned by institutional investors, who hold approximately 79.8% of total shares outstanding. Company insiders own approximately 20.00%, while retail and public investors account for the remaining 0.19%.
The largest institutional shareholder of Biohaven Ltd. is BLACKROCK, INC., holding approximately 7.87 million shares — equal to 7.69% of outstanding shares — as of September 30, 2025.
A total of 300 institutional investors currently hold BHVN stock, with a combined institutional value of approximately $1.27 billion as of the most recent 13F filing period.
Frequently asked questions
BHVN ownershipBiohaven Ltd. (BHVN) is primarily owned by institutional investors, who hold approximately 79.8% of shares. The largest shareholder is BLACKROCK, INC. with a 7.69% stake. Company insiders hold 20.00%. Data sourced from SEC Form 13F as of September 30, 2025.